Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

Must Read

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1
Incheon, South Korea–(Antara/Business Wire.

Latest News

Indonesia eyes smart city cooperation to deepen ASEAN-Pacific Alliance

..ASEAN and the Pacific Alliance represent two regions that are increasingly connected, Jakarta (ANTARA) - Indonesia sees smart city cooperation...

More Articles Like This